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Abstract. The high complexity of deep learning models is associated
with the difficulty of explaining what evidence they recognize as correlat-
ing with specific disease labels. This information is critical for building
trust in models and finding their biases. Until now, automated deep
learning visualization solutions have identified regions of images used by
classifiers, but these solutions are too coarse, too noisy, or have a limited
representation of the way images can change. We propose a novel method
for formulating and presenting spatial explanations of disease evidence,
called deformation field interpretation with generative adversarial net-
works (DeFI-GAN). An adversarially trained generator produces defor-
mation fields that modify images of diseased patients to resemble images
of healthy patients. We validate the method studying chronic obstruc-
tive pulmonary disease (COPD) evidence in chest x-rays (CXRs) and
Alzheimer’s disease (AD) evidence in brain MRIs. When extracting dis-
ease evidence in longitudinal data, we show compelling results against
a baseline producing difference maps. DeFI-GAN also highlights disease
biomarkers not found by previous methods and potential biases that may
help in investigations of the dataset and of the adopted learning methods.
Keywords: Deformation Field · Deep Learning Interpretation · Visual
Attribution · Adversarial Training · Disease Effect · DeFI-GAN
1 Introduction
The recent surge of deep learning applications has the potential to revolutionize
medical imaging in several ways, such as accessibility, efficiency, and flexibility.
However, decision automation leads to challenges, including the interpretability
of the outcomes [21]. Understanding what kinds of evidence deep learning meth-
ods capture from an image is one approach for overcoming these challenges.
Data used in preparation of this article were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu).
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The field can benefit from such understanding through improvements in user
trustworthiness, patient communication, and model bias identification.
Among visual attribution methods, backpropagation through a trained classi-
fier is commonly used to determine areas of stronger influence on the model out-
put [2]. Several visual attribution approaches have been applied to medical imag-
ing. The class activation map (CAM) [37] method has been employed to show
low-resolution areas of focus when performing pneumonia diagnosis from a chest
x-ray (CXR) [27]. CAM has also been used as part of a weakly-supervised fine
segmentation of lung nodules [10]. Layer-wise relevance propagation (LRP) [4]
has been used to find biases in a histopathology dataset [17]. Despite their use-
fulness, most visual attribution methods are too coarse or too noisy for some
applications [6]. They also have limited means of representing their findings,
which may obscure relevant evidence.
Spatial deformations have been used in several applications, including regis-
tration [5], generation of adversarial examples [36], and creation of atlases [9].
While deformation fields may not be adequate for producing color and texture
changes, they can generate variations in position, shape, and size. Since some
impacts of diseases on anatomy are linked to the latter, we hypothesize that
applying deformation fields to represent and visualize model interpretations will
better include such variations. We propose the deformation field interpretation
with generative adversarial networks (DeFI-GAN) method, which uses adver-
sarial training [14] to learn to produce a deformation field that alters an image
to make disease signs indiscernible. Therefore, the changes caused by this field
express evidence of such disease. To the best of our knowledge, no other work
has used deformation fields for visual attribution in deep learning.
We perform experiments studying evidence of chronic obstructive pulmonary
disease (COPD) in CXRs [35, 13]. In [7], automatic assessment of COPD evi-
dence is also performed. However, this assessment applies additive perturbations
instead of deformation fields, and a different set of disease evidence is found.
The method presented in [7] also models disease severity, which is not a focus
of DeFI-GAN. We also employ the ADNI dataset to model the conversion from
mild cognitive impairment (MCI) to Alzheimer’s disease (AD) through the mor-
phological brain changes observed in MRIs [22]. In [6], generative adversarial
training is also used to assess evidence of AD in brain MRIs. This setup inspires
our method, but uses additive perturbations instead of deformation fields and a
different regularization loss function. We analyze the outcomes of the proposed
formulation in both datasets, showing that the use of DeFI-GAN improves longi-
tudinal prediction over a baseline [6] and highlights additional disease evidence.
2 Method
We consider binary classification problems, where class 0 is associated with
healthy patients and class 1 with diseased patients. Each image in a dataset
is denoted by x, and its domain by X. Images of class c are indicated by xc. Our
objective is to find a transformation f that maps from an image x1 containing
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Fig. 1. Overall model architecture. The terms LDx0 , LDxˆ0 , and LG are WGAN losses,
whereas LRegD penalizes the gradient of D, and LRegG penalizes the complexity of φ.
evidence for a disease to a modified image xˆ0 where that evidence is absent. The
rest of the content, e.g. patient specific anatomy, should not be modified. We
propose to model f as a deformation controlled by a generated vector field, as
shown in Figure 1. Mathematically,
φ = G(x1), xˆ0(p) = x1(p+ φ(p)), p ∈ X, (1)
where G is a parameterized generator mapping from x1 to vector field φ : X →
X. Since p + φ(p) can lie between the set of coordinates on the grid for which
we have defined values in x1, we use bilinear interpolation when X ∈ R2, and
trilinear interpolation when X ∈ R3. When p + φ(p) lies outside the range for
which values are defined in x1, values in xˆ0 are set to 0.
To learn the parameters of transformation f , we follow [6] and use adversarial
training. We train G jointly with a parameterized critic D tasked with discrimi-
nating modified images xˆ0 from real images x0. The generator G is trained to fool
D, using the gradient signal from D so that the distribution of xˆ0 approaches the
distribution of x0. For the adversarial loss, we use the WGAN [3] formulation.
The critic D is trained to give high scores for modified images and low scores
for real images, resulting in
LD = LDx0 − LDxˆ0 = E [D(x0)]− E [D(xˆ0)] . (2)
To enforce the Lipschitz constraint required by the WGAN formulation [3], we
use the penalty proposed in [15],
LRegD = E
[
(‖∇x˜D(x˜)‖2 − 1)2 | x˜ ∼ (1− α)x0 + αxˆ0, α ∼ U(0, 1)
]
, (3)
where U(0, 1) is the uniform distribution with support between 0 and 1. The
expectation is approximated by sampling one α for each sampled (x0, x1) pair.
The generator G is trained to lower the scores for xˆ0, resulting in
LG = E [D(xˆ0)] . (4)
To penalize extraneous changes and enforce smooth and realistic deformations,
we use a total variation denoising [29] penalty over φ. This term forces nearby
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vectors to be aligned by penalizing
∫
X
‖∇φ‖2. After discretization,
LRegG = E
[
1
P
∑
p∈X
∑
n∈N (p) ‖φ(p)− φ(n)‖2
]
, (5)
whereN (p) is the set of neighboring pixels of pixel p (4-neighborhood for X ∈ R2
and 6-neighborhood for X ∈ R3) and P is the total number of pixels.
The complete optimization formulation is given by
G∗ = argmin
G
(LG + λRegGLRegG), D
∗ = argmin
D
(LD + λRegDLRegD), (6)
where λRegG and λRegD are hyperparameters.
3 Experiments
We tested our method3 in two datasets, one for finding evidence of AD in brain
MRIs and one for detecting signs of COPD in CXRs. We used as a baseline the
visual attribution generative adversarial network (VA-GAN) method [6], where
the function to obtain xˆ0 is defined by the addition of a difference map, i.e., xˆ0 =
x1+G(x1), and the penalty on G is accordingly defined by LRegG = ‖xˆ0 − x1‖1.
We used u-nets [28] asG’s architecture, varying the number of downsamplings
and channels depending on the dataset. We used the Adam optimizer [20] with
a learning rate of 1e−4 and set λRegD = 10. For D’s architecture, we used an
ImageNet pre-trained Resnet-18 [16] for the CXR dataset and a 10-layer network
as in [6] for the MRI dataset. For training the DeFI-GAN method, we performed
100 updates to D for each update to G, whereas for VA-GAN, the 100:1 update
ratio was used for the first 25 updates to G, and then changed to a 5:1 ratio. It
was important for the convergence of G to have X represented in pixel units.
3.1 Chronic obstructive pulmonary disease in chest x-rays
We collected a dataset containing posterioranterior (PA) CXRs acquired at the
University of Utah Hospital from 2012 to 2017. Each CXR was labeled for COPD
using results from pulmonary function tests (PFTs) taken within one month of
the CXR. Patients who received a lung transplant were excluded. Patients with
COPD were assigned to class 1, and others were assigned to class 0. The training
set was composed of patients who had only one CXR included in the dataset
and contained 2,226 images from normal patients and 963 images from COPD
patients. We worked under an approved Institutional Review Board (IRB)4 and
anonymized data using Orthanc5. Image preprocessing included center-cropping
to a square, resizing to 256×256, cropping to 224×224 (randomly for training
and centered for validation and testing), and equalizing histograms.
3 The DeFI-GAN code is available at https://github.com/ricbl/defigan
4 IRB 00104019, PI: Schroeder MD
5 orthanc-server.com
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3.2 Alzheimer’s disease in brain MRIs
The ADNI dataset was collected to characterize the progression of AD and con-
tains brain MRIs of thousands of subjects followed for a few years [1]. Diagnosis
of AD and MCI are provided for each exam. Following [6], we set class 0 to MCI
patients, instead of healthy patients, and class 1 to AD patients, training G to
provide interpretations for the conversion from MCI to AD. We also limited our
study to T1-weighted MRIs from the ADNI1, ADNIGO, and ADNI2 cohorts.
Data splits and part of the preprocessing were replicated from [6]6. For each
image, we used the FMRIB Software Library (FSL) toolbox [32] v6.0 for reorien-
tation and field of view (FOV) cropping, N4 Bias Correction [34] from Advanced
Normalization Tools (ANTs) v3.0 for bias field correction, FSL to register the
image to the MNI 152 space [11, 12], and ROBEX [18] v1.2 for skull stripping.
To correct cases where ROBEX failed, we added another step of skull stripping
to the whole dataset using the Brain Extraction Tool (BET) [31] with a frac-
tional intensity threshold equal to 0.25. All volumes were rescaled to a size of
128 × 160 × 112 pixels. Through visual inspection, we searched for cases where
the brain volume was incorrectly oriented, or skull stripping had failed, and re-
moved 7 volumes from 4 subjects from test and validation. The preprocessing
differed from [6] in the application of BET and in the elimination of the 7 cases
for which preprocessing failed. The final training set had 2,528 MCI volumes and
1,198 AD volumes, for a total of 825 subjects.
3.3 Quantitative Validation
We validated our generated disease evidence by using longitudinal scans demon-
strating disease progression. For the COPD dataset, we paired all test cases
where a subject was healthy in the baseline CXR with cases of the same subject
after developing COPD. For each pair, we performed an affine registration of
the normal case to the COPD case using SimpleITK v1.2 [24]. We then sub-
tracted the COPD image from the registered baseline image to get a difference
ground truth ∆x. The final split sizes were 206 pairs of images (176 subjects)
for validation and 547 pairs (354 subjects) for testing. For the ADNI dataset,
we performed rigid registration instead of affine, disregarding the background
for the calculations, and used MCI cases as the baseline, pairing them with AD
MRIs taken with the same field strength. The final split sizes were 207 pairs (102
subjects) for validation and 259 pairs (143 subjects) for testing.
The ground truth ∆x and the predicted difference ∆̂x = xˆ0 − x1 were com-
pared using normalized cross-correlation (NCC), masked to ignore regions pad-
ded during registration and skull stripping. This operation was defined by
NCC (∆x, ∆̂x) =
1
M − 1
∑
p∈M
(∆x (p)− µ∆x)
σ∆x
× (∆̂x (p)− µ∆̂x)
σ∆̂x
, (7)
6 VA-GAN’s original preprocessing code, list of subjects, and TensorFlow implemen-
tation are available in https://github.com/baumgach/vagan-code/
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Table 1. NCC scores for the compared methods. Averages of 5 models trained with
different random seeds are reported with their standard deviations.
Method/Dataset VA-GAN DeFI-GAN
ADNI 0.332 ± 0.015 0.365± 0.014
COPD 0.174 ± 0.007 0.204± 0.006
DeFI-GAN VA-GAN
Original Image Modified Image Modifications Modified Image Modifications
Fig. 2. Comparison of results of DeFI-GAN and VA-GAN on the COPD dataset. Green
represents darkening of the image, and pink represents brightening.
where M is the number of pixels in the mask M, and µi and σi are, respec-
tively, the average value and the unbiased standard deviation of values of pixels
of image i inside mask M. One subject may have had more than one pair of
validation images. The score calculated for all pairs of each subject was averaged
before calculating the final average score to avoid the over-representation of a
few subjects in the final score.
Hyperparameters were chosen by considering image quality and validation
NCC score. With the DeFI-GAN method, we used λRegG = 25 for the COPD
dataset and λRegG = 10 for the ADNI dataset, whereas for the VA-GAN method
we used, respectively, λRegG = 50 and λRegG = 100. The original VA-GAN
TensorFlow implementation was used for the ADNI dataset.
Test scores are reported in Table 1, where the DeFI-GAN method is shown
to outperform the baseline. The scores for the ADNI dataset when using VA-
GAN are better than the ones presented in [6]. This difference is probably due to
choosing the best training epoch using the NCC validation score instead of loss
values. It is interesting to note that training was less noisy for the DeFI-GAN
method when considering the validation scores from epoch to epoch. Relatively
low NCC scores may result from the difficulty in aligning longitudinal data and
from aging effects in the ground truth.
3.4 Biomarker Validation
We compared the interpretations provided by DeFI-GAN and VA-GAN and
present some results in Figures 2 and 3. The difference maps were computed
using xˆ0 − x1. Additional results are presented in the supplementary material.
For the COPD dataset, both approaches identified changes in heart silhouette
Interpretation of Disease Evidence Using Adversarial Deformation Fields 7
DeFI-GAN VA-GAN
Original Views Difference Modifications Difference Modifications
Fig. 3. Results on the ADNI dataset when removing evidence of AD from the original
image. Green represents darkening of the image, and pink represents brightening.
and in diaphragm height and curvature, which are notable characterizations of
COPD in CXRs [35, 13]. We found no variation in lung lucency. The lack of
change in texture was expected for the DeFI-GAN method from its formulation.
Interpretations from the VA-GAN method were less spatially smooth.
Saber-sheath trachea is a secondary sign of COPD, and, when it occurs,
there is a narrowing of the trachea in the frontal CXR [8]. This evidence was
more identifiable in models trained with DeFI-GAN when looking at quiver plot
visualization, as seen in Figure 4(a). The VA-GAN method cannot produce this
kind of deformation field visualization. In the difference map produced by the
VA-GAN method, the changes in the top of the image appeared as a dark fuzzy
alteration. Another sign more easily identified with DeFI-GAN was the change
in soft-tissue thickness, as shown in Figure 4(b). This change is in accordance
with the correlation between low body mass index (BMI) and COPD [38].
Although we focused the analysis on COPD, we also found the results in
the ADNI dataset consistent with the literature. The main changes associated
with AD, expansion of ventricles, hippocampus atrophy, and temporal lobe at-
rophy [22], are seen in Figure 3. It was possible to find, in some cases, atrophies
in the precuneus, the cerebellum, and the brainstem. These regions have been
associated with AD [30, 33, 23]. The rest of the cortex also presented atrophies
to a lesser extent. The differences highlighted by both methods were similar,
except for VA-GAN having more image noise, more darkening differences, and
more noticeable highlighting of the hippocampus, which is favorable evidence.
A detailed representation of a deformation field in MRIs can be seen in the
supplementary material.
Unexpected changes in COPD Some evidence pinpointed by the DeFI-GAN
method in the COPD dataset is not usually listed in the literature. Figure 4(c)
shows a decrease in gastric bubble size. This change may represent a confusion
between the lower border of the gastric bubbles and the diaphragm, or be related
to aerophagia due to coughing [25]. Furthermore, the shoulder position changed
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(a)
(b)
(c)
(d)
(e)
DeFI-GAN VA-GAN
Original Image Deformation Field Modified Image Difference Map Modified Image
Fig. 4. Details on the generated deformation fields and comparison with VA-GAN. The
color of the arrows represents their length. For rows a-c, their length represents the
exact shift in pixels. In rows d-e, their length is multiplied by 2 for better visualization.
The full-size images are presented in the supplementary material. From top to bottom:
(a) trachea; (b) soft tissue; (c) gastric bubble; (d) shoulder; (e) lung apex.
in a few images, as seen in Figure 4(d). High clavicle position might be related
to a decrease in shoulder mobility [26] and, consequently, difficulty in following
the required body positioning for the standing CXR acquisition. It may also
be related to a bias in spine position due to the prevalence of osteoporosis [19]
in patients with COPD. In Figure 4(e), the expansion of the top of the lungs
contradicts larger lung volumes in COPD patients. However, when analyzed by a
radiologist, lung volume still seemed larger in the original images, probably due
to diaphragm height. This change may be correlated with the clavicle positioning
since it increases lung volume above the clavicle. The change in gastric bubble
size and the expansion of the top of the lung were, in a less comprehensible
representation, also highlighted by the VA-GAN method. All these unexpected
differences may also represent dataset biases. A more in-depth investigation of
the causes for these changes is left to subsequent studies.
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4 Conclusion
We formulated a method for producing interpretations of the disease evidence
that deep learning models can capture from imaging data, using deformation
fields and adversarial training. This method performed better in the proposed
longitudinal quantitative validation on two medical datasets, when compared to
another method with a similar goal. Furthermore, it allowed for easier discovery
of qualitative disease evidence used by the model. As exemplified by some of
the highlighted COPD evidence, this study has the potential to support future
analyses of unexpected biases in medical imaging datasets.
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1Supplementary Material
Fig. 1. Deformation field for an ADNI image. Arrow length is multiplied by 5.
DeFI-GAN VA-GAN
Original Views Difference Modifications Difference Modifications
Fig. 2. Additional results for the ADNI dataset.
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Fig. 3. Full-size images of the portions used in Figure 4 in the main paper: A) cropped
regions labeled by their row labels over the original image; B) deformation field with
arrow length scaled by 2; C) image modified by DeFI-GAN; D) VA-GAN difference
map; E) image modified by VA-GAN.
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Original Image Modified Image Modifications Modified Image Modifications
Fig. 4. Additional results for the COPD dataset.
